Joseph Elliot, Ph.D., President & CEO
Dr. Elliot is the founding President & CEO of Receptor Therapeutics Inc. Dr. Elliot is well known and highly regarded in the Canadian biotechnology industry. From 1996 to 1999 he was a Vice President (Venture Capital) with MDS Capital Corp. specializing in early stage Canadian biotechnology investments. Subsequently he has played a leading management role with several biotech companies including President & CEO of LymphoSign Inc., Vice President & General Manager Operations for MDS Proteomics Inc.; Chief Operating Officer for MDS Ocata Inc.; Interim Chief Operating Officer of Exogen Neurosciences Inc. He is the former President and Chairman of PhageTech Inc. of Montreal, Quebec and Cytochroma Inc., Kingston Ontario. He is also a past director of Nexia Biotechnologies Inc. of Montreal, Quebec, and BIOSTAR Inc. of Saskatoon, Saskatchewan.
From 1986 to 1996 Dr. Elliot founded and successfully operated several companies, which sold and distributed vaccines and sera in over 100 countries worldwide. Prior to 1986, he held senior technical and marketing positions with Pharmacia Canada Inc. (now Pfizer) and Connaught Laboratories Inc. (now Sanofi Aventis). Dr. Elliot received his Ph.D. in Medical Sciences from the Faculty of Health Sciences, McMaster University, Hamilton, Ontario in 1980.